EN
HI
Aurobindo Pharma Chart
Aurobindo Pharma Share Key Metrics
Volume
25.07 L
Market Cap
86992.47 CR
LTQ@LTP
1@1497.80
ATP
1478.16
Var Margin
14.46 %
Circuit Range
1299.4-1588
Delivery %
53.05 %
Value
370.51 CR
ASM/GSM
No
Market Lot
1
Summary
Aurobindo Pharma share price is ₹1497.8 as of 19 Jun, 2026. The stock Aurobindo Pharma intraday movement has stayed between ₹1446.40 and ₹1503.10, while on a 52-week basis,Aurobindo Pharma price 52 week high is ₹1550.00 & its 52 week low is ₹1016.10.
In terms of trading activity, Aurobindo Pharma has recorded a volume of 2506592 shares, The Aurobindo Pharma has a market cap of ₹580801623 CR. The stock’s Average Traded Price (ATP) stands at ₹1478.16, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1497.80.
Aurobindo Pharma operates within a circuit range of ₹1299.40 – ₹1588.00, with a Value of ₹370.51 CR. The Delivery Percentage for the day is 53.05%. Additionally, Aurobindo Pharma currently falls under the No framework, and trades with a market lot size of 1.
Aurobindo Pharma Fundamentals
P/E Ratio
23.69
P/B Ratio
2.19
Div. Yield
0.28
Sector P/E
69.1
Sector P/B
3.04
Sec. Div. Yield
0.53
Aurobindo Pharma Resistance and Support
Pivot 1435.83
Resistance
First Resistance
1455.56
Second Resistance
1467.43
Third Resistance
1487.16
Support
First Support
1423.96
Second Support
1404.23
Third Support
1392.36
Aurobindo Pharma Futures & Options
Aurobindo Pharma Option Chain
View Price, OI, Greeks & More...
30JUN26
1503.00
55.90 (3.86%)
28JUL26
1509.50
53.80 (3.70%)
25AUG26
1515.00
51.80 (3.54%)
AUROPHARMA|30JUN26 CE 1480.00
36.00
22.15 (159.93%)
AUROPHARMA|30JUN26 PE 1500.00
25
-50 (-66.67%)
Aurobindo Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-21 | Audited Results |
| 2026-04-06 | Buy Back of Shares |
| 2026-02-09 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-04 | Quarterly Results & Interim Dividend |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
Aurobindo Pharma News
Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Aurobindo Pharma USA Inc. obtained the necessary approval from the US Federal Trade Commission (FTC) for its 100% acquisition of Lannett Company LLC from LANNETT SELLER HOLDCO, INC. The transaction is expected to close before the end of this month.
Jun 19 2026 08:24:32
Aurobindo Pharma Ltd - 524804 - Classification Of US FDA Inspection At Unit-III Of Eugia Pharma Specialities Limited, Pashamylaram (Our Wholly Owned Subsidiary) As OAI
Aurobindo Pharma's wholly owned subsidiary, Eugia Pharma Specialities, received an Official Action Indicated (OAI) classification from the US FDA for its Unit-III formulation manufacturing facility. The inspection, conducted from January 27 to February 06, 2026, concluded with 11 observations.
Jun 12 2026 18:17:06
Read More
Aurobindo Pharma Management
| Name | Position |
|---|---|
| Mangalam Ramasubramanian Kumar | Chairman |
| K Nityananda Reddy | Vice Chairman & Managing Director |
Aurobindo Pharma Similar Stocks
Dr. Reddy's Laboratories Ltd.
1272.10
4.60 (0.36%)
Lupin Ltd.
2351.60
24.50 (1.05%)
Max Healthcare Institute Ltd.
1094.75
4.30 (0.39%)
Mankind Pharma Ltd.
2414.20
8.20 (0.34%)
Lenskart Solutions Ltd.
511.95
6.90 (1.37%)
Laurus Labs Ltd.
1412.90
44.10 (3.22%)
Fortis Healthcare Ltd.
962.95
4.20 (0.44%)
Biocon Ltd.
415.50
1.65 (0.40%)
Alkem Laboratories Ltd.
5373.50
1.50 (0.03%)
Glenmark Pharmaceuticals Ltd.
2213.60
59.60 (2.77%)
Aurobindo Pharma FAQs
The Buying Price of Aurobindo Pharma share is 1497.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aurobindo Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 23.69. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.19. Useful to assess the stock's value relative to its book value.
To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 69.1 & 3.04 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aurobindo Pharma is 86992.47 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aurobindo Pharma share price is 1550.00 & 1016.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aurobindo Pharma belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
Invest in AUROPHARMA
Or Download Choice FinX App
Invest in AUROPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade